MLB

Mets pitcher Noah Syndergaard tests positive for covid-19

Associated Press
By Associated Press
2 Min Read Aug. 29, 2021 | 4 years Ago
Go Ad-Free today

NEW YORK — Mets right-hander Noah Syndergaard encountered another hurdle in his recovery from Tommy John surgery Sunday when he was scratched from a rehab start because he tested positive for covid-19, a person familiar with the situation told the Associated Press.

The person spoke to the AP on condition of anonymity because the team has not announced the test result. New York manager Luis Rojas said Sunday that Syndergaard had a “nonbaseball-related injury.” He did confirm that Syndergaard has been vaccinated.

Syndergaard — who turned 29 Sunday — tweeted, “This birthday is so sick.”

Syndergaard, who hasn’t pitched in the majors since Sept. 29, 2019, had the surgery just after the pandemic shutdown in March 2020. He began a rehab assignment this spring but left his second start with Low-A St. Lucie on May 26 with right elbow inflammation.

Syndergaard, who is scheduled to reach free agency after the season, didn’t pitch again until Thursday’s rehab outing, when he gave up one run in one inning. Afterward, he said he wasn’t throwing his slider or curveball because doctors believed the off-speed pitches bothered his elbow.

With no time to build Syndergaard up to a typical starter’s workload, the Mets are hoping he could rejoin the team as a reliever. He had been expected to throw at least an inning Sunday for Singe-A Brooklyn.

Share

Categories:

Tags:

About the Writers

Sports and Partner News

Push Notifications

Get news alerts first, right in your browser.

Enable Notifications

Content you may have missed

Enjoy TribLIVE, Uninterrupted.

Support our journalism and get an ad-free experience on all your devices.

  • TribLIVE AdFree Monthly

    • Unlimited ad-free articles
    • Pay just $4.99 for your first month
  • TribLIVE AdFree Annually BEST VALUE

    • Unlimited ad-free articles
    • Billed annually, $49.99 for the first year
    • Save 50% on your first year
Get Ad-Free Access Now View other subscription options